LDT Foundations Webinar Series: Exploring Standards that Support LDT Developers in Stage 1

Includes a Live Web Event on 10/30/2024 at 1:00 PM (EDT)

Join CLSI for a webinar series dedicated to the stages of FDA's Final Rule on Laboratory Developed Tests (LDTs). Register now for all webinars and receive access to the entire series that will provide practical guidance, resources, and vital information for laboratories. Once you are registered for the series, you will receive notifications about new webinars that are released, all on-demand recordings, and webinar slides. CLSI will update this series frequently with new webinar dates, topics, and other LDT resources.

The second webinar is an overview and guide to of Stage 1 of FDA's Final Rule on LDTs, including resources for your laboratory to implement into practice. The webinar will include guidance for implementing stage 1, an overview of useful CLSI documents, and a Q&A discussion.

Webinar 2 | Wednesday, October 30, 1:00 PM ET | Guidance for Stage 1 

Introduction and Updates to the FDA's Final Rule on LDTs | Shannon Bennett, MS
Guidance for Stage 1 | Christopher Dailey, PhD
Overview of QMS11 and QMS18 | Lucia Berte  
Q&A Discussion | Moderated by Shannon Bennett, Featuring Michelle Campbell MS, MLS(ASCP)MB,SC

Webinar 2 Learning Objectives 

  1. Describe three steps you can take to prepare for stage 1 of FDA's final rule regarding LDTs. 
  2. Identify two resources that your laboratory can use to prepare for stage 1. 

Webinar 1 | Thursday, August 15, 1:00 PM ET | An Overview of FDA's Final Rule on LDTs 

The first webinar is a panel discussion and overview of the FDA's Final Rule on LDTs, including practical resources for your laboratory to implement into practice.

Webinar 1 | Webinar Agenda

Overview of the Ruling | Shannon Bennett, MS, MBA, CMQOE(ASQ)

Q&A Discussion | Michelle Campbell MS, MLS(ASCP)MB, SC; Jonathan Genzen, MD, PhD, MBA; Shannon Bennett, MS, MBA, CMQOE(ASQ)

Method Navigator as a LDT Resource | Tabitha Kern, MS, MLS(ASCP)


Webinar 1 Learning Objectives 

  1. Describe three main takeaways from the FDA's Final Rule on Laboratory Developed Tests (LDTs). 
  2. Identify two resources that your laboratory can use to prepare for the ruling. 


Earn 2.0 P.A.C.E. credits for the first two webinars. 

Upcoming Webinars

Webinar 3 | Design Controls | Winter 2025

Webinar 4 | TBD, Spring 2025


CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Key:

Complete
Failed
Available
Locked
Submit Q&A Webinar Questions
1 Question
1 Question We will save time for a live Q&A, but if you have any questions ahead of time, please submit them here for consideration.
Exploring Standards that Support LDT Developers in Stage 1
10/30/2024 at 1:00 PM (EDT)  |  60 minutes
10/30/2024 at 1:00 PM (EDT)  |  60 minutes
Webinar 1: Overview of FDA's Final Rule on LDTs On-Demand Recording
Introduction and Overview of the Ruling
Open to view video.  |  10 minutes
Open to view video.  |  10 minutes
Method Navigator as an LDT Resource
Open to view video.  |  4 minutes
Open to view video.  |  4 minutes
Panel Discussion
Open to view video.  |  44 minutes
Open to view video.  |  44 minutes
Webinar 1 Evaluation
12 Questions
Webinar 1 P.A.C.E. Credit and Certificate
1.00 P.A.C.E. credit  |  Certificate available
1.00 P.A.C.E. credit  |  Certificate available